Clinical Trial Update: Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial update for convection-enhanced delivery of MDNA55 in adults with recurrent or progressive glioblastoma; study completed with results posted in 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• MDNA55

Snippet

Sponsor: Medicenna Therapeutics, Inc. | Conditions: Glioblastoma, Grade IV Astrocytoma | Phase 2 | Status: COMPLETED | Results posted: 2022-10-24